
Executive Medical Director – Translational Medicine Group Leader - Neurology
- Stevenage, Hertfordshire
- Permanent
- Full-time
- Provide disease-level leadership, to develop causal maps of relevant pathobiology (through identifying, accessing or generating translational datasets), and the tools/instruments (endpoints, biomarkers) that enable timely experimentation and prosecution to derisk mechanisms and programmes.
- strategic leadership for the design, execution, and management to clinical development plans and clinical trials for programmes in the Early Pipeline Unit
- Provide translational and clinical leadership in defining and executing innovative early development strategies. Provide strategic leadership assuring that the clinical study designs are aligned with the IEP and CDP, and take into account the scientific rationale, regulatory requirements, product development plan and commercial goals.
- Stay abreast of advancements in TA research, clinical trial methodologies, and regulatory changes to maintain GSK’s competitive edge.
- Actively contribute to regulatory interactions, including briefing documents, presentations, and responses.
- Contribute to Business Development activities, including due diligence projects.
- Champion the implementation of translational and biomarker strategies across therapeutic areas.
- Lead the Disease Area Acceleration Team (DAAT), ensuring alignment of scientific and clinical strategies with business objectives through matrix leadership of large cross-functional teams.
- Drive the evaluation of therapeutic potential and clinical tractability of targets within the disease area.
- Identify transformational opportunities where projects can offer significant benefits to patients.
- Ensure quality, on-time, and on-budget delivery of studies and programs within a therapeutic area of EPU
- Design and implement experimental medicine studies to
- Oversee risk assessment across programs and ensure implementation of mitigation strategies.
- Manage, mentor and coach early Clinical Development Leads to foster a culture of empowerment, innovation and excellence.
- Collaborate with cross-functional teams with program counterparts in Advance Pipeline Unit, Commercial, Research Tech and Development organisations.
- Build and maintain networks across internal and external stakeholders, including academic institutions, CROs, and regulators.
- Represent GSK effectively in external collaborations and negotiations.
- Anticipate challenges and proactively develop strategies to mitigate risks.
- Make decisions balancing risk/benefit with clear understanding of project impact.
- Written and Oral Communication:
- Lead the writing and review of study-related documents and regulatory submissions.
- Communicate confidently and effectively at all levels, internally and externally.
- Champion implementation of innovative business processes and strategies to improve clinical development outcomes.
- Physician scientist with board qualification/registration in Neurology
- Strong Industry experience in neurodegenerative clinical drug development
- Thorough understanding of the neurodegenerative therapy area including underlying biology and potential therapeutic targets
- In-depth experience with planning clinical development for a neurdegenerative asset and/or indication
- Significant neurodegenerative clinical trials and projects experience (e.g., deriving causal confidence from novel sources, or qualifying a novel endpoint)
- Experience in translational medicine, clinical research methodology and principles of biostatistics to facilitate innovative and efficient designs of clinical trials and clinical development plans with clear data-driven decision rules
- Strong leadership experience including direct line management, coaching, mentoring and individual/team development
- In addition to Neurologist credentials, holding a higher research degree (e.g., PhD) or other demonstrable research expertise (e.g., Faculty appointments)
- Experience working collaboratively with multiple stakeholders on complex projects.
- Track record of building and maintaining strong relationships with internal and external stakeholders
- Strong personal network across relevant scientific and clinical thought leaders, institutions and consortia in neurology